(WASHINGTON) — U.S. officials confirm that two U.S. Air Force stealth …
Senator Walz Introduces
(WASHINGTON) — U.S. officials confirm that two U.S. Air Force stealth …
Dawson County
As Fortune detailed in a recent magazine feature ... But the algorithms aren't always sophisticated enough to tell the difference between Isis the stock and ISIS the terrorist organization. Last year, Ionis's CEO (which was …
Fortune
Those losses may temporarily place a cap on Isis' stock price over say the next one-to-three years. However, should even a handful of Isis' programs succeed it'll more than validate the value of Isis' antisense platform and …
It's been a tough year for ISIS Pharmaceuticals investors. After a remarkable 281% return in 2013, shares have gone absolutely nowhere in 2014. That flat-line return is even more disappointing considering that the S&P 500 …
BMO capital has affirmed an Outperform rating for Isis Pharmaceutical, Inc. (NASDAQ: ISIS) stock with a 12 month price target of $75. The rating was based on Isis's announcement on February 5, that it has received …
The past six weeks haven't been too pretty for shareholders of predominantly clinical-stage biotech stock Isis Pharmaceuticals (NASDAQ: ISIS). Since peaking at a closing price of $77.08 on March 19, 2015, shares have …
Isis
Matthew M. Reed is Vice President of Foreign Reports, Inc., a Washington, DC-based consulting firm focused on oil and politics in the Middle East. In spite of a year-long U.S.-led bombing campaign, ISIS is still producing …
Islamic State in Iraq and the Levant
The Stock now has the market capitalization of $1.18 Billion ... He …
Gigamon Inc
Yesterday, ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) delivered some rather sobering mid-stage results for …